Skip to main content
OpenTrials
Completed

NCT Number: NCT00915798

Association Between Smoking, Brain Activity, Genes, and ADHD

The study investigated the underlying mechanisms of smoking in young adults by examining the associations between smoking, brain activity, dopamine genes, and attention deficit hyperactivity disorder (ADHD).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Observational

Primary location

2500 Red Hill Avenue

Santa Ana, California, 92705, United States

About this study

The study investigated the underlying mechanisms of smoking in young adults by examining the associations between smoking, brain activity, dopamine genes, and attention deficit hyperactivity disorder (ADHD). Four groups of young adults were recruited: (1) smokers with ADHD; (2) nonsmokers with ADHD; (3) normative control smokers; and (4) normative control nonsmokers. Smoking was assessed via questionnaires and salivary cotinine levels. Brain activity was examined via functional Magnetic Resonance Imaging (fMRI). Each nonsmoker underwent an fMRI scan during an experimental task consisting of mathematical problems. Smokers underwent two fMRI scans during similar experimental tasks under the following two conditions: (1) after smoking a cigarette and (2) after overnight abstinence. The association between the DRD4-7 repeat allele and smoking was explored.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Smokers with ADHD
  • Cigarette smoking for the last year
  • ADHD diagnosis
  • Nonsmokers with ADHD
  • No history of regularly smoking cigarettes
  • ADHD diagnosis
  • Normative control smokers
  • Cigarette smoking for the last year
  • No history and diagnosis of ADHD
  • Normative control nonsmokers
  • No history of regularly smoking cigarettes
  • No history and diagnosis of ADHD

Exclusion criteria

  • Children under the age of 18
  • Adults above the age of 45
  • Pregnancy or planning to become pregnant
  • Any major medical illness
  • Any mental disorders that require medication (except stimulant medication)
  • Any contraindications to fMRI scanning
  • Not speaking English

Treatment and study plan

Cigarette Smoking

Behavioral

Participants had an fMRI scan during an experimental task consisting of mathematical problems after smoking a cigarette.

Abstinence

Behavioral

Participants had an fMRI scan during an experimental task consisting of mathematical problems after smoking abstinence.

Primary outcomes

  1. Brain Activity

    Time frame: One MRI session for nonsmokers and two MRI sessions for smokers

    BOLD z-score of smokers with ADHD after abstinence/smoking a cigarette, control smokers after abstinence/smoking a cigarette, nonsmokers with ADHD, and control nonsmokers. All participants performed a mathematical task in the MRI scanner. Higher BOLD z-scores indicate greater brain activation.

Secondary outcomes

  1. DRD4 Genotype

    Time frame: one time blood draw

  2. Salivary Cotinine

    Time frame: Once per week for 4 weeks

    Average level of salivary cotinine over all time points (microgram/milliliter)

Sponsors and collaborators

Lead sponsor

University of California, Irvine

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Smoking, Neurocircuitry and Genes in Adult ADHD

Important dates

Study start
2009
Primary completion
2016
Study completion
2016
First posted
Jun 8, 2009
Registry last updated
Jan 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.